Prof. Dr. Jan Siemens

Wissenschaftlicher Werdegang

seit 2013: Professorship - Department of Pharmacology, Heidelberg University
Group leader in the Molecular Medicine Partnership Unit (EMBL, Heidelberg)
2009 – 2013: Junior Group Leader at the Max Delbrück Center in Berlin
2005 – 2009: Postdoctoral Fellow
Departments of Physiology and Cellular & Molecular Pharmacology
University of California, San Francisco
Advisor: Prof. Dr. David Julius
2004: PhD degree (summa cum laude) in Cellbiology, University of Basel, Switzerland
2000 – 2004: PhD Graduate student
Friedrich-Miescher Institute (FMI) in Basel, Switzerland & The Scripps Research Institute in San Diego, USA
(Lab relocated to The Scripps Research Institute in 2003)
1999 – 2000: Diploma Thesis (Diplom Biochemist)
Institute for Diabetis Research
Eberhard-Karls-University, Tübingen, Germany
Advisor: PD Dr. Reiner Lammers (Director: Dr. Ulrich Haering)
1994 – 1999: Biochemistry undergraduate studies,
University of Bochum and University of Frankfurt a.M.

2018: ERC Consolidator Award (European Research Council)
2017: Sir Hans Krebs-Preis (Medizinische Hochschule Hannover)
2017: PHOENIX Pharmacy Science Award (Phoenix group)
2015: Galenus-von-Pergamon Award (Springer Medizin; patronage: BMBF)
2011: ERC Starting Grant (European Research Council)
2009: Career Development Award (Human Frontier Science Program - HFSP)
2008: Sofja Kovalevskaja Award (Alexander von Humboldt Foundation - BMBF)
2008: K99/R00 Pathway to Independence Award (NIH)
2007: Sandler Postdoctoral Research Award
2006: Postdoctoral Fellowship, Human Frontier Science Program Organization (HFSP)
2005: Postdoctoral Fellowship, Swiss National Research Foundation and the Novartis Research Foundation
2004: Most outstanding Ph.D. Thesis-Award selected by the Faculty for Natural Sciences (Philosophisch - Naturwissenschaftliche Fakultät II), University of Basel, Switzerland
2001: Ph.D. fellowship from the Boehringer Ingelheim Fonds, Germany

seit 2019: Dean of Research of the Medical Faculty, Heidelberg University
seit 2013: Faculty member of the Molecular Medical Partnership Unit (MMPU), a joint research venture between EMBL and the Heidelberg University Clinic (www.embl.de/mmpu/)
seit 2013: Associated faculty member of the “International Graduate School of Molecular & Cellular Biology” (HBIGS - www.hbigs.uni-heidelberg.de)
seit 2013: Reviewer for the Medical Research Council (MRC), UK
2011 – 2013: Representative of all Junior Group Leaders at the Max-Delbrück Center (MDC), Berlin, Germany
seit 2010: Reviewer for several scientific journals including Science, Nature, Nature Communications, Neuroscience, Pain and Molecular Pain